Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
Bone|June 4, 2008
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) studyStephen Kaptoge, Jose A da Silva, Kim Brixen, et al.The Journal of Clinical Endocrinology and Metabolism|April 24, 2012
Sex steroid-induced changes in circulating monocyte chemoattractant protein-1 levels may contribute to metabolic dysfunction in obese menJohannes B Ruige, Marlies Bekaert, Bruno Lapauw, et al.Molecular and Cellular Endocrinology|June 15, 2007
Estrogen receptor signaling is an unstable feature of the gonadotropic LbetaT2 cell lineFrank Eertmans, Olivier De Wever, De Wever Olivier, et al.Aging Clinical and Experimental Research|March 28, 2021
2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpointSwan Sim Yeap, Aree Tanavalee, Emmanuel C Perez, et al.The New England Journal of Medicine|November 2, 2012
Fracture risk and zoledronic acid therapy in men with osteoporosisSteven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al.Aging Clinical and Experimental Research|June 21, 2024
Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the artNicholas R Fuggle, Jean-Yves Reginster, Nasser Al-Daghri, et al.Aging Clinical and Experimental Research|August 19, 2019
Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)Adolfo Diez-Perez, Maria Luisa Brandi, Nasser Al-Daghri, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.Advances in Therapy|August 24, 2019
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for OsteoporosisMattias Lorentzon, Jaime Branco, Maria Luisa Brandi, et al.Calcified Tissue International|May 18, 2019
Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature ReviewJürgen M Bauer, Alfonso J Cruz-Jentoft, Roger A Fielding, et al.Pageof 17